Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

 
 

Persistent Macular Thickening After Ranibizumab Treatment
for Diabetic Macular Edema With Vision Impairment

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

 
 
 

Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab

Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

diabetes1

 

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

diabetes2

 

Persistent Macular Thickening After Ranibizumab Treatment
for Diabetic Macular Edema With Vision Impairment

diabetes3

 

Reduction of Vascular Endothelial Growth Factor A in Human Breast Milk After Intravitreal Injection of Bevacizumab but Not Ranibizumab

diabetes4